Straits Times Index
3,084.08 -6.23 (-0.20%) S&P 500
4,594.63 +26.83 (+0.59%) Dow
36,245.50 +294.60 (+0.82%) Nasdaq
14,305.03 +78.83 (+0.55%) Bitcoin USD
41,700.77 +2,244.73 (+5.69%) CMC Crypto 200
862.05 +70.49 (+8.91%)
ABT May 2024 90.000 put
| Previous close | 1.4000 |
| Open | 1.5100 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 90.00 |
| Expiry date | 2024-05-17 |
| Day's range | 1.4000 - 1.5100 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
ZacksAbbott (ABT) Rises Higher Than Market: Key Facts
Abbott (ABT) closed the most recent trading day at $104.29, moving +0.64% from the previous trading session.
Motley FoolAbbVie Should Consider a Dividend Cut -- Here's Why
Since its split from Abbott Laboratories in 2013, AbbVie (NYSE: ABBV) has been the third best-performing stock in terms of total returns on capital (assuming the dividend was reinvested) on the esteemed list of Dividend Kings. AbbVie's top-shelf performance has been due to two main factors. First up, the company successfully expanded Humira's label at a breakneck pace over this period, transforming it into the world's first pharma product to exceed $20 billion a year in sales.
ZacksWall Street Bulls Look Optimistic About Abbott (ABT): Should You Buy?
According to the average brokerage recommendation (ABR), one should invest in Abbott (ABT). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
